<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20250207</date><key>collection.key</key><document><id>PMC5400574</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.18632/oncotarget.15504</infon><infon key="article-id_pmc">PMC5400574</infon><infon key="article-id_pmid">28416752</infon><infon key="article-id_publisher-id">15504</infon><infon key="fpage">21167</infon><infon key="issue">13</infon><infon key="kwd">CDKN2B single nucleotide polymorphism glaucoma meta-analysis rs1063192</infon><infon key="license">This article is distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.</infon><infon key="lpage">21176</infon><infon key="name_0">surname:Hu;given-names:Zhenxian</infon><infon key="name_1">surname:He;given-names:Chenliang</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">8</infon><infon key="year">2017</infon><offset>0</offset><text>CDKN2B gene rs1063192 polymorphism decreases the risk of glaucoma</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>66</offset><text>The aim of this meta-analysis was to evaluate the association between cyclin-dependent kinase Inhibitor-2B (CDKN2B) gene rs1063192 polymorphism and glaucoma risk. We searched the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fixed-effect or random-effect models. A total of 14 case-control studies involving 11,316 cases and 24,055 controls were included. Meta-analysis showed that CDKN2B gene rs1063192 polymorphism was associated with a decreased risk of glaucoma. Stratification analysis of ethnicity indicated that rs1063192 polymorphism decreased the risk of glaucoma among Caucasians and Asians. Stratification analysis by type of glaucoma revealed that rs1063192 polymorphism conferred a protective factor of primary open-angle glaucoma (POAG) and non-POAG. Stratification by source of controls uncovered an association between rs1063192 polymorphism and glaucoma in groups of population-based controls. In conclusion, this meta-analysis indicates that CDKN2B gene rs1063192 polymorphism is significantly associated with a decreased risk of glaucoma.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1196</offset><text>INTRODUCTION</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1209</offset><text>Glaucoma is the second-leading cause of irreversible blindness in the world. Data has been estimated that over 11.1 million people will be bilaterally blind from primary glaucoma by 2020. Glaucoma is characterized by degeneration of the optic nerve, and is usually associated with increased intraocular pressure. The main types of glaucoma include primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG). To date, the main pathogenesis for disease progression in glaucoma is still poorly understood. Studies suggested that various risk factors of glaucoma included age, elevated intraocular pressure (IOP), variable susceptibility of the optic nerve, vascular factors, diabetes, myopia, a positive family history and cigarette smoking. Genetic factors also have been reported to play a vital role in the pathogenesis of glaucoma. Previous linkage-based studies demonstrated several genes were associated with glaucoma, including myocilin, CYP1B1, optineurin, and WDR36. Recent genome-wide association studies (GWASs) have identified several genetic variants associated with glaucoma, including cyclin-dependent kinase Inhibitor-2B (CDKN2B) gene.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2376</offset><text>CDKN2B has been identified to play an important role in G1 progression of the cell cycle. Animal studies demonstrated that elevated IOP is associated with overexpression of CDKN2B, which leads to disruption in cell cycle causing abnormal cell proliferation. GWAS studies for glaucoma showed direct association of CDKN2B region of 9p21 locus with glaucoma, identifying its significance as a risk factor. A host of studies investigated the association between CDKN2B gene rs1063192 polymorphism and glaucoma susceptibility, but with conflicting findings. However, these studies were conflicting and inconclusive due to clinical heterogeneity, different ethnic populations, and small sample sizes. Therefore, we performed a comprehensive meta-analysis to clarify the possible association between CDKN2B gene rs1063192 polymorphism and glaucoma risk.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>3223</offset><text>RESULTS</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>3231</offset><text>Characteristics of the included studies</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>3271</offset><text>We yielded a total of 76 citations the by searches of the PubMed and Embase databases and manual searching. 43 citations were removed after removing duplicates and screening the titles and abstracts. 33 citations were selected for further full text review. 19 citations (3 citations did not conform to the inclusion criteria; 6 investigated other polymorphisms; 5 did not provide detailed genotyping data; 1 overlapped with previous study; 3 were reviews; and 1 was not case-control study) were excluded after serious review. 14 eligible studies (11,316 cases and 24,055 controls) in this meta-analysis finally. Selection for eligible studies included in this meta-analysis was presented in Figure 1. The characteristics of the individual studies included in the meta-analysis are summarized in Table 1. The Newcastle-Ottawa Scale (NOS) scores of all included studies ranged from 6 to 7 stars, suggesting that these studies were of high methodological quality.</text></passage><passage><infon key="file">oncotarget-08-21167-g001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>4232</offset><text>Selection for eligible publications included in this meta-analysis</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>4299</offset><text>Characteristics of included studies</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;box&quot; rules=&quot;all&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Author and year&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Country&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genotype methods&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Case&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Control&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HWE&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NOS&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TT&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TC&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TT&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TC&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Abu-Amero2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Saudi Arabia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;53&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;58&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;31&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ng2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Australia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unclear&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;941&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1022&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;278&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1004&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1564&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;608&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Burdon2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Australia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;28&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;31&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;579&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;950&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;390&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chen2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;China&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unclear&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;770&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;348&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;592&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;303&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Williams2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;South Africa&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;215&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;214&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;N&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Philomenadin2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;India&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;56&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;35&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;220&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;131&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mabuchi2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Japan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;301&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;113&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;115&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;66&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Micheal2014&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pakistan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;270&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;206&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;37&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;127&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;89&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liu2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;USA&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unclear&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;980&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;163&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;875&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;120&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liu2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;USA&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unclear&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;483&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;591&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;N&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cao2012&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;USA&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;251&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;135&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;29&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Osman2012&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Japan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;962&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;391&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4155&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2156&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;280&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Osman2012&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Japan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1267&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;486&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4452&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2425&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;330&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dimasi2012&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Australia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unclear&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;348&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;408&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;120&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;274&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;430&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;169&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Takamoto2012&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Japan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;109&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;38&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;120&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;60&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fan2011&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Netherland&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TaqMan&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;170&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;172&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;102&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;155&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;51&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Y&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4335</offset><text>Author and year	SOC	Country	Genotype methods	Ethnicity	Case			Control			HWE	NOS	 						TT	TC	CC	TT	TC	CC			 	Abu-Amero2016	HB	Saudi Arabia	PCR	Caucasian	53	32	2	58	31	5	Y	6	 	Ng2016	PB	Australia	Unclear	Caucasian	941	1022	278	1004	1564	608	Y	7	 	Burdon2015	PB	Australia	PCR	Caucasian	28	31	8	579	950	390	Y	7	 	Chen2015	HB	China	Unclear	Asian	770	348	39	592	303	39	Y	7	 	Williams2015	HB	South Africa	PCR	African	215	0	0	214	0	0	N	6	 	Philomenadin2015	HB	India	PCR	Asian	56	35	6	220	131	20	Y	6	 	Mabuchi2015	HB	Japan	PCR	Asian	301	113	11	115	66	10	Y	7	 	Micheal2014	HB	Pakistan	PCR	Asian	270	206	37	127	89	17	Y	7	 	Liu2013	PB	USA	Unclear	African	980	163	7	875	120	4	Y	7	 	Liu2013	PB	USA	Unclear	African	483	0	0	591	2	0	N	6	 	Cao2012	PB	USA	PCR	African	251	21	0	135	29	1	Y	7	 	Osman2012	PB	Japan	PCR	Asian	962	391	40	4155	2156	280	Y	6	 	Osman2012	PB	Japan	PCR	Asian	1267	486	47	4452	2425	330	Y	7	 	Dimasi2012	PB	Australia	Unclear	Caucasian	348	408	120	274	430	169	Y	7	 	Takamoto2012	HB	Japan	PCR	Asian	109	38	4	120	60	7	Y	7	 	Fan2011	PB	Netherland	TaqMan	Caucasian	170	172	47	102	155	51	Y	6	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>5426</offset><text>SOC, source of controls; PB, population-based controls; HB, hospital-based controls; HWE, HardyâWeinberg Equilibrium; NOS, Newcastle-Ottawa Scale.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5575</offset><text>Meta-analysis of CDKN2B gene rs1063192 polymorphism with glaucoma risk</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5646</offset><text>A summary of association between CDKN2B gene rs1063192 polymorphism with glaucoma risk is provided in Tables 2 and 3. In the overall analysis, we detected a significant association between CDKN2B gene rs1063192 polymorphism with the decreased risk of glaucoma (CC vs. TT: OR, 0.55; 95% CI, 0.49â0.61, P &lt; 0.001, Figure 2). Stratification by ethnicity indicated that rs1063192 polymorphism was also significantly associated with a decreased risk of glaucoma among Caucasians and Asians (C vs. T, Figure 3). Similar result was also replicated among Africans in the allele model (C vs. T, Figure 3). Stratification analysis by type of glaucoma suggested that rs1063192 polymorphism was a protective factor of POAG and non-POAG (TT vs. CT + CC, Figure 4). Stratification by source of controls (SOCs) revealed an association between rs1063192 polymorphism and glaucoma in groups of population-based controls.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>6552</offset><text>Meta-analysis of association between CDKN2B rs1063192 polymorphism and the risk of glaucoma</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;box&quot; rules=&quot;all&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Comparison&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OR(95%CI)&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;-value&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt; for heterogeneity&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;I&lt;sup&gt;2&lt;/sup&gt; (%)&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Model&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C vs. T&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.79 (0.72,0.87)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;68.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Random&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC + TC vs. TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.76 (0.68,0.85)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;69.2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Random&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC vs. TT + TC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.64 (0.58,0.71)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.730&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.0&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fixed&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC vs. TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.55 (0.49,0.61)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.286&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15.3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fixed&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TC vs. TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.94 (0.82,1.07)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;59.3&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Random&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>6644</offset><text>Comparison	OR(95%CI)	P-value	P for heterogeneity	I2 (%)	Model	 	C vs. T	0.79 (0.72,0.87)	&lt; 0.001	&lt; 0.001	68.2	Random	 	CC + TC vs. TT	0.76 (0.68,0.85)	&lt; 0.001	&lt; 0.001	69.2	Random	 	CC vs. TT + TC	0.64 (0.58,0.71)	&lt; 0.001	0.730	0.0	Fixed	 	CC vs. TT	0.55 (0.49,0.61)	&lt; 0.001	0.286	15.3	Fixed	 	TC vs. TT	0.94 (0.82,1.07)	&lt; 0.001	0.002	59.3	Random	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>6993</offset><text>* Bold values are statistically significant (P &lt; 0.05).</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>7049</offset><text>Summary of the subgroup analyses in this meta-analysis</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;box&quot; rules=&quot;all&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Comparison&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Category&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Category&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Studies&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OR (95% CI)&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;-value&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt; for heterogeneity&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C vs. T&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.71 (0.67,0.72)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.724&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.81 (0.72,0.91)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.013&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.79 (0.72,0.87)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.404&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of glaucoma&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.78 (0.70,0.87)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.81 (0.63,1.04)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.096&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.037&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.88 (0.75,1.02)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.080&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.174&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.75 (0.67,0.83)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC + TC vs. TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.66 (0.60,0.72)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.575&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.79 (0.69,0.90)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.026&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.63 (0.22,1.84)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.402&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of glaucoma&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.75 (0.66,0.86)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.78 (0.56,1.09)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.143&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.038&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.87 (0.73,1.03)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.204&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.71 (0.62,0.82)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.107&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC vs.TC + TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.62 (0.54,0.70)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.898&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.67 (0.56,0.80)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.493&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.12 (0.38,3.34)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.838&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.247&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of glaucoma&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.63 (0.56,0.70)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.719&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.69 (0.55,0.86)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.375&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.80 (0.59,1.08)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.148&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.701&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.62 (0.55,0.69)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.779&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CC vs.TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.51 (0.44,0.58)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.907&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.62 (0.51,0.74)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.258&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.13 (0.38,3.35)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.831&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.216&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of glaucoma&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.55 (0.48,0.63)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.371&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.63 (0.41,0.96)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.033&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.142&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.78 (0.58,1.06)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.108&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.560&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.52 (0.47,0.59)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.581&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TC vs.TT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caucasian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.71 (0.65,0.78)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.615&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.80 (0.71,0.90)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.081&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;African&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.64 (0.23,1.81)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.404&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of glaucoma&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.78 (0.69,0.88)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-POAG&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.83 (0.63,1.10)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.190&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.122&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SOC&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.89 (0.76,1.04)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.138&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.294&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.75 (0.66,0.85)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt; 0.001&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.004&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>7104</offset><text>Comparison	Category	Category	Studies	OR (95% CI)	P-value	P for heterogeneity	 	C vs. T	Ethnicity	Caucasian	5	0.71 (0.67,0.72)	&lt; 0.001	0.724	 			Asian	7	0.81 (0.72,0.91)	&lt; 0.001	0.013	 			African	3	0.79 (0.72,0.87)	0.404	0.001	 		Type of glaucoma	POAG	12	0.78 (0.70,0.87)	&lt; 0.001	&lt; 0.001	 			Non-POAG	3	0.81 (0.63,1.04)	0.096	0.037	 		SOC	HB	6	0.88 (0.75,1.02)	0.080	0.174	 			PB	9	0.75 (0.67,0.83)	&lt; 0.001	0.001	 	CC + TC vs. TT	Ethnicity	Caucasian	5	0.66 (0.60,0.72)	&lt; 0.001	0.575	 			Asian	7	0.79 (0.69,0.90)	&lt; 0.001	0.026	 			African	3	0.63 (0.22,1.84)	0.402	0.001	 		Type of glaucoma	POAG	12	0.75 (0.66,0.86)	&lt; 0.001	&lt; 0.001	 			Non-POAG	3	0.78 (0.56,1.09)	0.143	0.038	 		SOC	HB	6	0.87 (0.73,1.03)	&lt; 0.001	0.204	 			PB	9	0.71 (0.62,0.82)	0.107	&lt; 0.001	 	CC vs.TC + TT	Ethnicity	Caucasian	5	0.62 (0.54,0.70)	&lt; 0.001	0.898	 			Asian	7	0.67 (0.56,0.80)	&lt; 0.001	0.493	 			African	2	1.12 (0.38,3.34)	0.838	0.247	 		Type of glaucoma	POAG	11	0.63 (0.56,0.70)	&lt; 0.001	0.719	 			Non-POAG	3	0.69 (0.55,0.86)	0.001	0.375	 		SOC	HB	6	0.80 (0.59,1.08)	0.148	0.701	 			PB	8	0.62 (0.55,0.69)	&lt; 0.001	0.779	 	CC vs.TT	Ethnicity	Caucasian	5	0.51 (0.44,0.58)	&lt; 0.001	0.907	 			Asian	7	0.62 (0.51,0.74)	&lt; 0.001	0.258	 			African	2	1.13 (0.38,3.35)	0.831	0.216	 		Type of glaucoma	POAG	11	0.55 (0.48,0.63)	&lt; 0.001	0.371	 			Non-POAG	3	0.63 (0.41,0.96)	0.033	0.142	 		SOC	HB	6	0.78 (0.58,1.06)	0.108	0.560	 			PB	8	0.52 (0.47,0.59)	&lt; 0.001	0.581	 	TC vs.TT	Ethnicity	Caucasian	5	0.71 (0.65,0.78)	&lt; 0.001	0.615	 			Asian	7	0.80 (0.71,0.90)	&lt; 0.001	0.081	 			African	3	0.64 (0.23,1.81)	0.404	0.002	 		Type of glaucoma	POAG	12	0.78 (0.69,0.88)	&lt; 0.001	0.002	 			Non-POAG	3	0.83 (0.63,1.10)	0.190	0.122	 		SOC	HB	6	0.89 (0.76,1.04)	0.138	0.294	 			PB	9	0.75 (0.66,0.85)	&lt; 0.001	0.004	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>8870</offset><text>SOC, source of control; PB, population-based controls; HB, hospital-based controls; POAG: Primary Open-Angle Glaucoma.</text></passage><passage><infon key="file">oncotarget-08-21167-g002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>8989</offset><text>Forest plot shows odds ratio for the associations between rs1063192 polymorphism and glaucoma risk (CC vs. TT)</text></passage><passage><infon key="file">oncotarget-08-21167-g003.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>9100</offset><text>Stratification analysis of ethnicity shows odds ratio for the association between rs1063192 polymorphism and glaucoma risk (C vs. T)</text></passage><passage><infon key="file">oncotarget-08-21167-g004.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>9233</offset><text>Stratification analysis of type of glaucoma between rs1063192 polymorphism and glaucoma risk (TT vs. CT + CC)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9343</offset><text>We assessed sensitivity by omitting each study once at a time in every genetic model for rs1063192 polymorphism. The pooled ORs for the effects of the single nucleotide polymorphism (SNP) on the risk for glaucoma risk indicated that our data was stable and trustworthy(C vs. T, Figure 5). Both Egger's and Begg's tests (CC vs. TT, Figure 6) were used to evaluated the publication bias of this meta-analysis. Our data showed no evidence of publication bias affecting the meta-analysis results. (data not shown).</text></passage><passage><infon key="file">oncotarget-08-21167-g005.jpg</infon><infon key="id">F5</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>9854</offset><text>Sensitivity analysis for rs1063192 polymorphism and glaucoma risk (C vs. T)</text></passage><passage><infon key="file">oncotarget-08-21167-g006.jpg</infon><infon key="id">F6</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>9930</offset><text>Begg's tests between rs1063192 polymorphism and glaucoma risk (CC vs. TT)</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>10004</offset><text>DISCUSSION</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10015</offset><text>In this meta-analysis, our data indicated that CDKN2B gene rs1063192 polymorphism with the decreased risk of glaucoma. Stratification analysis by ethnicity found that rs1063192 polymorphism decreased the risk of glaucoma among Caucasians, Asians and Africans. Stratification analysis by type of glaucoma revealed that rs1063192 polymorphism was associated with a decreased risk of POAG and non-POAG.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10415</offset><text>Genes at the 9p21 locus, including CDKN2B, are strong candidates for POAG risk. CDKN2B gene plays a vital role in cell cycle, development and function of ophthalmic disorders. Several GWASs among different ethnic groups provided strong evidence that gene variants at the CDKN2B locus of 9p21 are a crucial risk factor in the development of POAG. Recently, a host of studies explored the association between CDKN2B gene rs1063192 polymorphism and glaucoma risk. However, these studies obtained conflicting results. The limitations of these studies including clinical heterogeneity, different ethnic populations, and small sample sizes may contribute to the disaccords. Although association studies provide a powerful means of identifying genetic factors underlying glaucoma, most reported association studies lack sufficient statistical power. In such cases, meta-analysis can be used as an alternative. Therefore, we conducted this comprehensive meta-analysis to demonstrate the association between CDKN2B gene rs1063192 polymorphism and glaucoma susceptibility. To the best of our knowledge, this is the first meta-analysis to explore the relationship between this SNP and glaucoma risk.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11604</offset><text>In this meta-analysis, we combined data from included studies to evaluate genetic association between CDKN2B gene rs1063192 polymorphism and glaucoma. Our results showed a significant association between this SNP and glaucoma. Meta-analysis showed a significant association between rs1063192 polymorphism and glaucoma risk in Caucasians, Asians, and Africans, indicating that there was no significant ethnic differences about this SNP. It is of note that we only found the positive finding among Africans in the allele model, but the other four genetic models failed to replicate this association. The result of stratification analysis among Africans should be interpreted with caution, because the racial stratification of CDKN2B gene rs1063192 polymorphism and glaucoma regarding Africans included only three studies, which is insufficient to provide conclusive evidence. Thus, further studies using larger numbers of subjects are required. As for the subgroup analysis by type of glaucoma, we found rs1063192 polymorphism was associated with a decreased risk of POAG and non-POAG patients. Although the clinical heterogeneity of POAG and non-POAG is evident, meta-analysis did not find any different results between them. It is noteworthy that this meta-analysis only included 3 studies with limited sample size for non-POAG. Hence, we could exclude the likelihood of false-positive associations.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13004</offset><text>We believe our meta-analysis has some strengths. One, we included 14 studies with 11,316 cases and 24,055 controls in this study and the sample size of this meta-analysis was large. Two, sensitivity analysis provided evidence that our data about CDKN2B gene rs1063192 polymorphism were trustworthy and robust. Three, the power analysis indicated that our study had a power of 99.0% to detect the effect of rs1063192 polymorphism on glaucoma susceptibility, assuming an OR of 0.76.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13485</offset><text>However, this meta-analysis has some limitations that require further consideration. First, due to limited data, we could not perform further stratification analyses of other potential factors, such as age and gender. Second, our results were based on unadjusted estimates for confounding factors, which might have affected the final conclusions. Third, we could not assess potential gene-gene and gene-environment interactions because of the lack of relevant data. Fourth, the ethnicity-specific meta-analysis included data from Caucasians, Asians, and Africans, and thus, our findings are only applicable to these ethnic groups. Fifth, some unpublished studies may have been missed, although our data indicated no evident publication bias. Sixth, CDKN2B gene rs1063192 polymorphism would be not enough to explain the associations between CDKN2B gene and glaucoma risk. Seventh, the heterogeneity of this meta-analysis was high in some genetic models. Last but not least, the sample size of stratification analysis was limited in some ethnicities.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14534</offset><text>In conclusion, this meta-analysis demonstrates that CDKN2B gene rs1063192 polymorphism is significantly associated with a decreased risk of glaucoma. Larger scale studies of populations with different ethnicities are necessary to explore the roles played by this SNP of CDKN2B gene during the pathogenesis of glaucoma.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>14853</offset><text>MATERIALS AND METHODS</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14875</offset><text>Identification of eligible studies and data extraction</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14930</offset><text>A literature search was performed in the databases of PubMed and Embase to identify studies through December 8, 2016. The following words were used: âtumor necrosis factor alpha inducible protein 3,â ââglaucoma,ââ ââprimary open angle glaucoma,ââ ââPOAG,ââ ââprimary angle closure glaucoma,ââ ââpolymorphism,ââ ââPACGââ âcyclin-dependent kinase Inhibitor-2Bâ and ââCDKN2Bââ. No restrictions were placed on the search. Hand screening was conducted in order to identify additional studies. The identified studies conformed to the following criteria: (1) studies that evaluated the association between glaucoma and CDKN2B gene rs1063192 polymorphism, (2) studied on human beings, (3) study provided sufficient data to calculate the odds ratios (ORs) and 95% confidence intervals (CIs), and P value, and (4) case-control study.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15818</offset><text>The relevant data were extracted from the original articles. The extracted information from all eligible studies including: name of first author, publication year, ethnicity, and genotype numbers of cases and controls. Two reviewers independently performed the extraction of data and assessed the study quality based on the NOS. Any discrepancies between the reviewers were resolved by consensus or by a third reviewer.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>16238</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16259</offset><text>Statistical manipulations were performed using the Stata 11.0 software (StataCorp, College Station, TX, USA). ORs and 95%CIs were used to assess the strength of associations between CDKN2B gene rs1063192 polymorphism and glaucoma risk. Stratification analysis was carried out by ethnicity, type of glaucoma and source of controls. Cochran's Q statistic was also used to assess within- and between study variation, and tests of heterogeneity were used to assess the null hypothesis that all studies evaluated the same effect. When a Q test indicated P &lt; 0.1 or I2 &gt; 50% indicated heterogeneity across studies, a random-effect model was used. Otherwise, the fixed-effects model was applied. Pooled ORs were calculated for allele model, dominant model, recessive model, homozygous model, and heterozygous model. Sensitivity analyses were performed by omitting each study in turn to determine the effect on the test of heterogeneity and evaluated the stability of the overall results. We assessed the departure from the HWE in the controls using Pearson's Ï2 test. Potential publication bias was assessed by Begger's and Egger's linear regression test; P &lt; 0.05 was considered to indicate statistically significant. The power of this meta-analysis was calculated with a significant value of 0.05.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">footnote</infon><offset>17554</offset><text>CONFLICTS OF INTEREST</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">footnote</infon><offset>17576</offset><text>The authors declare no conflicts of interest.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>17622</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17636</offset><text>CDKN2B</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17643</offset><text>cyclin-dependent kinase Inhibitor-2B</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17680</offset><text>POAG</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17685</offset><text>primary open-angle glaucoma</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17713</offset><text>PACG</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17718</offset><text>primary angle closure glaucoma</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17749</offset><text>IOP</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17753</offset><text>intraocular pressure</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17774</offset><text>CI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17777</offset><text>confidence interval</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17797</offset><text>OR</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17800</offset><text>odds ratio</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17811</offset><text>NOS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17815</offset><text>Newcastle-Ottawa Scale</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17838</offset><text>SNP</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17842</offset><text>single nucleotide polymorphism</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17873</offset><text>GWAS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>17878</offset><text>Genome-wide association studies</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>17910</offset><text>REFERENCES</text></passage><passage><infon key="fpage">262</infon><infon key="lpage">267</infon><infon key="name_0">surname:Quigley;given-names:HA</infon><infon key="name_1">surname:Broman;given-names:AT</infon><infon key="pub-id_pmid">16488940</infon><infon key="section_type">REF</infon><infon key="source">The British journal of ophthalmology</infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">2006</infon><offset>17921</offset><text>The number of people with glaucoma worldwide in 2010 and 2020</text></passage><passage><infon key="fpage">1711</infon><infon key="lpage">1720</infon><infon key="name_0">surname:Weinreb;given-names:RN</infon><infon key="name_1">surname:Khaw;given-names:PT</infon><infon key="pub-id_pmid">15158634</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">363</infon><infon key="year">2004</infon><offset>17983</offset><text>Primary open-angle glaucoma</text></passage><passage><infon key="fpage">233</infon><infon key="lpage">239</infon><infon key="name_0">surname:Worley;given-names:A</infon><infon key="name_1">surname:Grimmer-Somers;given-names:K</infon><infon key="pub-id_pmid">21896259</infon><infon key="section_type">REF</infon><infon key="source">Aust J Prim Health</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2011</infon><offset>18011</offset><text>Risk factors for glaucoma: what do they really mean?</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">339</infon><infon key="name_0">surname:Liu;given-names:Y</infon><infon key="name_1">surname:Allingham;given-names:RR</infon><infon key="pub-id_pmid">21871452</infon><infon key="section_type">REF</infon><infon key="source">Experimental eye research</infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">2011</infon><offset>18064</offset><text>Molecular genetics in glaucoma</text></passage><passage><infon key="fpage">3064</infon><infon key="lpage">3072</infon><infon key="name_0">surname:Fan;given-names:BJ</infon><infon key="name_1">surname:Wiggs;given-names:JL</infon><infon key="pub-id_pmid">20811162</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">120</infon><infon key="year">2010</infon><offset>18095</offset><text>Glaucoma: genes, phenotypes, and new directions for therapy</text></passage><passage><infon key="fpage">668</infon><infon key="lpage">670</infon><infon key="name_0">surname:Stone;given-names:EM</infon><infon key="name_1">surname:Fingert;given-names:JH</infon><infon key="name_10">surname:Mackey;given-names:DA</infon><infon key="name_11">surname:Ritch;given-names:R</infon><infon key="name_12">surname:Kalenak;given-names:JW</infon><infon key="name_2">surname:Alward;given-names:WL</infon><infon key="name_3">surname:Nguyen;given-names:TD</infon><infon key="name_4">surname:Polansky;given-names:JR</infon><infon key="name_5">surname:Sunden;given-names:SL</infon><infon key="name_6">surname:Nishimura;given-names:D</infon><infon key="name_7">surname:Clark;given-names:AF</infon><infon key="name_8">surname:Nystuen;given-names:A</infon><infon key="name_9">surname:Nichols;given-names:BE</infon><infon key="pub-id_pmid">9005853</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">275</infon><infon key="year">1997</infon><offset>18155</offset><text>Identification of a gene that causes primary open angle glaucoma</text></passage><passage><infon key="fpage">1077</infon><infon key="lpage">1079</infon><infon key="name_0">surname:Rezaie;given-names:T</infon><infon key="name_1">surname:Child;given-names:A</infon><infon key="name_10">surname:Crick;given-names:RP</infon><infon key="name_11">surname:Sarfarazi;given-names:M</infon><infon key="name_2">surname:Hitchings;given-names:R</infon><infon key="name_3">surname:Brice;given-names:G</infon><infon key="name_4">surname:Miller;given-names:L</infon><infon key="name_5">surname:Coca-Prados;given-names:M</infon><infon key="name_6">surname:Heon;given-names:E</infon><infon key="name_7">surname:Krupin;given-names:T</infon><infon key="name_8">surname:Ritch;given-names:R</infon><infon key="name_9">surname:Kreutzer;given-names:D</infon><infon key="pub-id_pmid">11834836</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">295</infon><infon key="year">2002</infon><offset>18220</offset><text>Adult-onset primary open-angle glaucoma caused by mutations in optineurin</text></passage><passage><infon key="fpage">725</infon><infon key="lpage">733</infon><infon key="name_0">surname:Monemi;given-names:S</infon><infon key="name_1">surname:Spaeth;given-names:G</infon><infon key="name_10">surname:Sarfarazi;given-names:M</infon><infon key="name_2">surname:DaSilva;given-names:A</infon><infon key="name_3">surname:Popinchalk;given-names:S</infon><infon key="name_4">surname:Ilitchev;given-names:E</infon><infon key="name_5">surname:Liebmann;given-names:J</infon><infon key="name_6">surname:Ritch;given-names:R</infon><infon key="name_7">surname:Heon;given-names:E</infon><infon key="name_8">surname:Crick;given-names:RP</infon><infon key="name_9">surname:Child;given-names:A</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2005</infon><offset>18294</offset><text>Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Human molecular genetics</text></passage><passage><infon key="fpage">574</infon><infon key="lpage">578</infon><infon key="name_0">surname:Burdon;given-names:KP</infon><infon key="name_1">surname:Macgregor;given-names:S</infon><infon key="name_10">surname:Landers;given-names:J</infon><infon key="name_11">surname:Henders;given-names:AK</infon><infon key="name_12">surname:Wood;given-names:J</infon><infon key="name_2">surname:Hewitt;given-names:AW</infon><infon key="name_3">surname:Sharma;given-names:S</infon><infon key="name_4">surname:Chidlow;given-names:G</infon><infon key="name_5">surname:Mills;given-names:RA</infon><infon key="name_6">surname:Danoy;given-names:P</infon><infon key="name_7">surname:Casson;given-names:R</infon><infon key="name_8">surname:Viswanathan;given-names:AC</infon><infon key="name_9">surname:Liu;given-names:JZ</infon><infon key="pub-id_pmid">21532571</infon><infon key="section_type">REF</infon><infon key="source">Nature genetics</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2011</infon><offset>18408</offset><text>Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1</text></passage><passage><infon key="fpage">257</infon><infon key="lpage">261</infon><infon key="name_0">surname:Hannon;given-names:GJ</infon><infon key="name_1">surname:Beach;given-names:D</infon><infon key="pub-id_pmid">8078588</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">371</infon><infon key="year">1994</infon><offset>18517</offset><text>p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest</text></passage><passage><infon key="fpage">1320</infon><infon key="lpage">1332</infon><infon key="name_0">surname:Iglesias;given-names:AI</infon><infon key="name_1">surname:Springelkamp;given-names:H</infon><infon key="name_10">surname:Uitterlinden;given-names:AG</infon><infon key="name_11">surname:Verdijk;given-names:RM</infon><infon key="name_12">surname:Klaver;given-names:CC</infon><infon key="name_2">surname:van der Linde;given-names:H</infon><infon key="name_3">surname:Severijnen;given-names:LA</infon><infon key="name_4">surname:Amin;given-names:N</infon><infon key="name_5">surname:Oostra;given-names:B</infon><infon key="name_6">surname:Kockx;given-names:CE</infon><infon key="name_7">surname:van den Hout;given-names:MC</infon><infon key="name_8">surname:van Ijcken;given-names:WF</infon><infon key="name_9">surname:Hofman;given-names:A</infon><infon key="pub-id_pmid">24150847</infon><infon key="section_type">REF</infon><infon key="source">Human molecular genetics</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2014</infon><offset>18588</offset><text>Exome sequencing and functional analyses suggest that SIX6 is a gene involved in an altered proliferation-differentiation balance early in life and optic nerve degeneration at old age</text></passage><passage><infon key="fpage">2836</infon><infon key="lpage">2842</infon><infon key="name_0">surname:Osman;given-names:W</infon><infon key="name_1">surname:Low;given-names:SK</infon><infon key="name_2">surname:Takahashi;given-names:A</infon><infon key="name_3">surname:Kubo;given-names:M</infon><infon key="name_4">surname:Nakamura;given-names:Y</infon><infon key="pub-id_pmid">22419738</infon><infon key="section_type">REF</infon><infon key="source">Human molecular genetics</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2012</infon><offset>18772</offset><text>A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma</text></passage><passage><infon key="fpage">e39278</infon><infon key="name_0">surname:Cao;given-names:D</infon><infon key="name_1">surname:Jiao;given-names:X</infon><infon key="name_2">surname:Liu;given-names:X</infon><infon key="name_3">surname:Hennis;given-names:A</infon><infon key="name_4">surname:Leske;given-names:MC</infon><infon key="name_5">surname:Nemesure;given-names:B</infon><infon key="name_6">surname:Hejtmancik;given-names:JF</infon><infon key="pub-id_pmid">22761751</infon><infon key="section_type">REF</infon><infon key="source">PloS one</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2012</infon><offset>18910</offset><text>CDKN2B polymorphism is associated with primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies</text></passage><passage><infon key="fpage">e40107</infon><infon key="name_0">surname:Takamoto;given-names:M</infon><infon key="name_1">surname:Kaburaki;given-names:T</infon><infon key="name_10">surname:Shirato;given-names:S</infon><infon key="name_11">surname:Yasuda;given-names:N</infon><infon key="name_12">surname:Kawashima;given-names:H</infon><infon key="name_2">surname:Mabuchi;given-names:A</infon><infon key="name_3">surname:Araie;given-names:M</infon><infon key="name_4">surname:Amano;given-names:S</infon><infon key="name_5">surname:Aihara;given-names:M</infon><infon key="name_6">surname:Tomidokoro;given-names:A</infon><infon key="name_7">surname:Iwase;given-names:A</infon><infon key="name_8">surname:Mabuchi;given-names:F</infon><infon key="name_9">surname:Kashiwagi;given-names:K</infon><infon key="pub-id_pmid">22792221</infon><infon key="section_type">REF</infon><infon key="source">PloS one</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2012</infon><offset>19042</offset><text>Common variants on chromosome 9p21 are associated with normal tension glaucoma</text></passage><passage><infon key="fpage">e0119703</infon><infon key="name_0">surname:Philomenadin;given-names:FS</infon><infon key="name_1">surname:Asokan;given-names:R</infon><infon key="name_2">surname:N;given-names:V</infon><infon key="name_3">surname:George;given-names:R</infon><infon key="name_4">surname:Lingam;given-names:V</infon><infon key="name_5">surname:Sarangapani;given-names:S</infon><infon key="pub-id_pmid">25798827</infon><infon key="section_type">REF</infon><infon key="source">PloS one</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2015</infon><offset>19121</offset><text>Genetic association of SNPs near ATOH7, CARD10, CDKN2B, CDC7 and SIX1/SIX6 with the endophenotypes of primary open angle glaucoma in Indian population</text></passage><passage><infon key="fpage">3416</infon><infon key="lpage">3421</infon><infon key="name_0">surname:Ng;given-names:SK</infon><infon key="name_1">surname:Burdon;given-names:KP</infon><infon key="name_10">surname:Graham;given-names:SL</infon><infon key="name_11">surname:Hewitt;given-names:AW</infon><infon key="name_12">surname:Mackey;given-names:DA</infon><infon key="name_2">surname:Fitzgerald;given-names:JT</infon><infon key="name_3">surname:Zhou;given-names:T</infon><infon key="name_4">surname:Fogarty;given-names:R</infon><infon key="name_5">surname:Souzeau;given-names:E</infon><infon key="name_6">surname:Landers;given-names:J</infon><infon key="name_7">surname:Mills;given-names:RA</infon><infon key="name_8">surname:Casson;given-names:RJ</infon><infon key="name_9">surname:Ridge;given-names:B</infon><infon key="pub-id_pmid">27367510</infon><infon key="section_type">REF</infon><infon key="source">Investigative ophthalmology &amp; visual science</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2016</infon><offset>19272</offset><text>Genetic Association at the 9p21 Glaucoma Locus Contributes to Sex Bias in Normal-Tension Glaucoma</text></passage><passage><infon key="fpage">1471</infon><infon key="lpage">1479</infon><infon key="name_0">surname:Micheal;given-names:S</infon><infon key="name_1">surname:Ayub;given-names:H</infon><infon key="name_2">surname:Khan;given-names:MI</infon><infon key="name_3">surname:Bakker;given-names:B</infon><infon key="name_4">surname:Schoenmaker-Koller;given-names:FE</infon><infon key="name_5">surname:Ali;given-names:M</infon><infon key="name_6">surname:Akhtar;given-names:F</infon><infon key="name_7">surname:Khan;given-names:WA</infon><infon key="name_8">surname:Qamar;given-names:R</infon><infon key="name_9">surname:den Hollander;given-names:AI</infon><infon key="pub-id_pmid">25489222</infon><infon key="section_type">REF</infon><infon key="source">Molecular vision</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2014</infon><offset>19370</offset><text>Association of known common genetic variants with primary open angle, primary angle closure, and pseudoexfoliation glaucoma in Pakistani cohorts</text></passage><passage><infon key="fpage">1819</infon><infon key="lpage">1825</infon><infon key="name_0">surname:Mabuchi;given-names:F</infon><infon key="name_1">surname:Sakurada;given-names:Y</infon><infon key="name_2">surname:Kashiwagi;given-names:K</infon><infon key="name_3">surname:Yamagata;given-names:Z</infon><infon key="name_4">surname:Iijima;given-names:H</infon><infon key="name_5">surname:Tsukahara;given-names:S</infon><infon key="pub-id_pmid">22584021</infon><infon key="section_type">REF</infon><infon key="source">Ophthalmology</infon><infon key="type">ref</infon><infon key="volume">119</infon><infon key="year">2012</infon><offset>19515</offset><text>Association between genetic variants associated with vertical cup-to-disc ratio and phenotypic features of primary open-angle glaucoma</text></passage><passage><infon key="fpage">6248</infon><infon key="lpage">6254</infon><infon key="name_0">surname:Liu;given-names:Y</infon><infon key="name_1">surname:Hauser;given-names:MA</infon><infon key="name_10">surname:Ritch;given-names:R</infon><infon key="name_11">surname:Moroi;given-names:SE</infon><infon key="name_12">surname:Pasquale;given-names:LR</infon><infon key="name_2">surname:Akafo;given-names:SK</infon><infon key="name_3">surname:Qin;given-names:X</infon><infon key="name_4">surname:Miura;given-names:S</infon><infon key="name_5">surname:Gibson;given-names:JR</infon><infon key="name_6">surname:Wheeler;given-names:J</infon><infon key="name_7">surname:Gaasterland;given-names:DE</infon><infon key="name_8">surname:Challa;given-names:P</infon><infon key="name_9">surname:Herndon;given-names:LW</infon><infon key="pub-id_pmid">23963167</infon><infon key="section_type">REF</infon><infon key="source">Investigative ophthalmology &amp; visual science</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2013</infon><offset>19650</offset><text>Investigation of known genetic risk factors for primary open angle glaucoma in two populations of African ancestry</text></passage><passage><infon key="fpage">1788</infon><infon key="lpage">1792</infon><infon key="name_0">surname:Fan;given-names:BJ</infon><infon key="name_1">surname:Wang;given-names:DY</infon><infon key="name_2">surname:Pasquale;given-names:LR</infon><infon key="name_3">surname:Haines;given-names:JL</infon><infon key="name_4">surname:Wiggs;given-names:JL</infon><infon key="pub-id_pmid">21398277</infon><infon key="section_type">REF</infon><infon key="source">Investigative ophthalmology &amp; visual science</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2011</infon><offset>19765</offset><text>Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population</text></passage><passage><infon key="comment">e832</infon><infon key="fpage">833</infon><infon key="lpage">842</infon><infon key="name_0">surname:Dimasi;given-names:DP</infon><infon key="name_1">surname:Burdon;given-names:KP</infon><infon key="name_2">surname:Hewitt;given-names:AW</infon><infon key="name_3">surname:Fitzgerald;given-names:J</infon><infon key="name_4">surname:Wang;given-names:JJ</infon><infon key="name_5">surname:Healey;given-names:PR</infon><infon key="name_6">surname:Mitchell;given-names:P</infon><infon key="name_7">surname:Mackey;given-names:DA</infon><infon key="name_8">surname:Craig;given-names:JE</infon><infon key="pub-id_pmid">22840486</infon><infon key="section_type">REF</infon><infon key="source">American journal of ophthalmology</infon><infon key="type">ref</infon><infon key="volume">154</infon><infon key="year">2012</infon><offset>19915</offset><text>Genetic investigation into the endophenotypic status of central corneal thickness and optic disc parameters in relation to open-angle glaucoma</text></passage><passage><infon key="fpage">2595</infon><infon key="lpage">2600</infon><infon key="name_0">surname:Chen;given-names:Y</infon><infon key="name_1">surname:Hughes;given-names:G</infon><infon key="name_2">surname:Chen;given-names:X</infon><infon key="name_3">surname:Qian;given-names:S</infon><infon key="name_4">surname:Cao;given-names:W</infon><infon key="name_5">surname:Wang;given-names:L</infon><infon key="name_6">surname:Wang;given-names:M</infon><infon key="name_7">surname:Sun;given-names:X</infon><infon key="pub-id_pmid">25711633</infon><infon key="section_type">REF</infon><infon key="source">Investigative ophthalmology &amp; visual science</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2015</infon><offset>20058</offset><text>Genetic Variants Associated With Different Risks for High Tension Glaucoma and Normal Tension Glaucoma in a Chinese Population</text></passage><passage><infon key="comment">e31</infon><infon key="fpage">31</infon><infon key="lpage">36</infon><infon key="name_0">surname:Burdon;given-names:KP</infon><infon key="name_1">surname:Mitchell;given-names:P</infon><infon key="name_2">surname:Lee;given-names:A</infon><infon key="name_3">surname:Healey;given-names:PR</infon><infon key="name_4">surname:White;given-names:AJ</infon><infon key="name_5">surname:Rochtchina;given-names:E</infon><infon key="name_6">surname:Thomas;given-names:PB</infon><infon key="name_7">surname:Wang;given-names:JJ</infon><infon key="name_8">surname:Craig;given-names:JE</infon><infon key="pub-id_pmid">25242315</infon><infon key="section_type">REF</infon><infon key="source">American journal of ophthalmology</infon><infon key="type">ref</infon><infon key="volume">159</infon><infon key="year">2015</infon><offset>20185</offset><text>Association of open-angle glaucoma loci with incident glaucoma in the Blue Mountains Eye Study</text></passage><passage><infon key="fpage">637</infon><infon key="lpage">641</infon><infon key="name_0">surname:Abu-Amero;given-names:KK</infon><infon key="name_1">surname:Kondkar;given-names:AA</infon><infon key="name_2">surname:Mousa;given-names:A</infon><infon key="name_3">surname:Almobarak;given-names:FA</infon><infon key="name_4">surname:Alawad;given-names:A</infon><infon key="name_5">surname:Altuwaijri;given-names:S</infon><infon key="name_6">surname:Sultan;given-names:T</infon><infon key="name_7">surname:Azad;given-names:TA</infon><infon key="name_8">surname:Al-Obeidan;given-names:SA</infon><infon key="pub-id_pmid">27541204</infon><infon key="section_type">REF</infon><infon key="source">Genetic testing and molecular biomarkers</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2016</infon><offset>20280</offset><text>Analysis of Cyclin-Dependent Kinase Inhibitor-2B rs1063192 Polymorphism in Saudi Patients with Primary Open-Angle Glaucoma</text></passage><passage><infon key="fpage">8378</infon><infon key="name_0">surname:Williams;given-names:SE</infon><infon key="name_1">surname:Carmichael;given-names:TR</infon><infon key="name_2">surname:Allingham;given-names:RR</infon><infon key="name_3">surname:Hauser;given-names:M</infon><infon key="name_4">surname:Ramsay;given-names:M</infon><infon key="pub-id_pmid">25669751</infon><infon key="section_type">REF</infon><infon key="source">Scientific reports</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2015</infon><offset>20403</offset><text>The genetics of POAG in black South Africans: a candidate gene association study</text></passage><passage><infon key="comment">e432</infon><infon key="fpage">437</infon><infon key="lpage">444</infon><infon key="name_0">surname:Mabuchi;given-names:F</infon><infon key="name_1">surname:Sakurada;given-names:Y</infon><infon key="name_2">surname:Kashiwagi;given-names:K</infon><infon key="name_3">surname:Yamagata;given-names:Z</infon><infon key="name_4">surname:Iijima;given-names:H</infon><infon key="name_5">surname:Tsukahara;given-names:S</infon><infon key="pub-id_pmid">25461262</infon><infon key="section_type">REF</infon><infon key="source">American journal of ophthalmology</infon><infon key="type">ref</infon><infon key="volume">159</infon><infon key="year">2015</infon><offset>20484</offset><text>Involvement of genetic variants associated with primary open-angle glaucoma in pathogenic mechanisms and family history of glaucoma</text></passage><passage><infon key="fpage">31</infon><infon key="lpage">67</infon><infon key="name_0">surname:Janssen;given-names:SF</infon><infon key="name_1">surname:Gorgels;given-names:TG</infon><infon key="name_2">surname:Ramdas;given-names:WD</infon><infon key="name_3">surname:Klaver;given-names:CC</infon><infon key="name_4">surname:van Duijn;given-names:CM</infon><infon key="name_5">surname:Jansonius;given-names:NM</infon><infon key="name_6">surname:Bergen;given-names:AA</infon><infon key="pub-id_pmid">24055863</infon><infon key="section_type">REF</infon><infon key="source">Progress in retinal and eye research</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2013</infon><offset>20616</offset><text>The vast complexity of primary open angle glaucoma: disease genes, risks, molecular mechanisms and pathobiology</text></passage><passage><infon key="fpage">3880</infon><infon key="lpage">3892</infon><infon key="name_0">surname:Li;given-names:Z</infon><infon key="name_1">surname:Allingham;given-names:RR</infon><infon key="name_10">surname:Sripriya;given-names:S</infon><infon key="name_11">surname:Fuse;given-names:N</infon><infon key="name_12">surname:Abu-Amero;given-names:KK</infon><infon key="name_2">surname:Nakano;given-names:M</infon><infon key="name_3">surname:Jia;given-names:L</infon><infon key="name_4">surname:Chen;given-names:Y</infon><infon key="name_5">surname:Ikeda;given-names:Y</infon><infon key="name_6">surname:Mani;given-names:B</infon><infon key="name_7">surname:Chen;given-names:LJ</infon><infon key="name_8">surname:Kee;given-names:C</infon><infon key="name_9">surname:Garway-Heath;given-names:DF</infon><infon key="pub-id_pmid">25861811</infon><infon key="section_type">REF</infon><infon key="source">Human molecular genetics</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2015</infon><offset>20728</offset><text>A common variant near TGFBR3 is associated with primary open angle glaucoma</text></passage><passage><infon key="fpage">e1002654</infon><infon key="name_0">surname:Wiggs;given-names:JL</infon><infon key="name_1">surname:Yaspan;given-names:BL</infon><infon key="name_10">surname:Budenz;given-names:DL</infon><infon key="name_11">surname:Caprioli;given-names:J</infon><infon key="name_12">surname:Crenshaw;given-names:A</infon><infon key="name_2">surname:Hauser;given-names:MA</infon><infon key="name_3">surname:Kang;given-names:JH</infon><infon key="name_4">surname:Allingham;given-names:RR</infon><infon key="name_5">surname:Olson;given-names:LM</infon><infon key="name_6">surname:Abdrabou;given-names:W</infon><infon key="name_7">surname:Fan;given-names:BJ</infon><infon key="name_8">surname:Wang;given-names:DY</infon><infon key="name_9">surname:Brodeur;given-names:W</infon><infon key="pub-id_pmid">22570617</infon><infon key="section_type">REF</infon><infon key="source">PLoS genetics</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2012</infon><offset>20804</offset><text>Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma</text></passage><passage><infon key="fpage">603</infon><infon key="lpage">605</infon><infon key="name_0">surname:Stang;given-names:A</infon><infon key="pub-id_pmid">20652370</infon><infon key="section_type">REF</infon><infon key="source">Eur J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2010</infon><offset>20922</offset><text>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</text></passage><passage><infon key="fpage">1539</infon><infon key="lpage">1558</infon><infon key="name_0">surname:Higgins;given-names:JP</infon><infon key="name_1">surname:Thompson;given-names:SG</infon><infon key="pub-id_pmid">12111919</infon><infon key="section_type">REF</infon><infon key="source">Stat Med</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2002</infon><offset>21048</offset><text>Quantifying heterogeneity in a meta-analysis</text></passage><passage><infon key="fpage">676</infon><infon key="lpage">680</infon><infon key="name_0">surname:Peters;given-names:JL</infon><infon key="name_1">surname:Sutton;given-names:AJ</infon><infon key="name_2">surname:Jones;given-names:DR</infon><infon key="name_3">surname:Abrams;given-names:KR</infon><infon key="name_4">surname:Rushton;given-names:L</infon><infon key="pub-id_pmid">16467236</infon><infon key="section_type">REF</infon><infon key="source">Jama</infon><infon key="type">ref</infon><infon key="volume">295</infon><infon key="year">2006</infon><offset>21093</offset><text>Comparison of two methods to detect publication bias in meta-analysis</text></passage><passage><infon key="fpage">203</infon><infon key="lpage">217</infon><infon key="name_0">surname:Hedges;given-names:LV</infon><infon key="name_1">surname:Pigott;given-names:TD</infon><infon key="pub-id_pmid">11570228</infon><infon key="section_type">REF</infon><infon key="source">Psychol Methods</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2001</infon><offset>21163</offset><text>The power of statistical tests in meta-analysis</text></passage></document>
</collection>